Jeena Sikho Lifecare Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2026, recommended Final Dividend of Rs. 4.50 per equity share.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeena Sikho Lifecare Limited reported strong FY2026 results with standalone revenue from operations growing 70.8% to Rs. 80,134.64 lakhs from Rs. 46,907.19 lakhs in FY2025. Profit after tax surged 177.9% to Rs. 22,217.57 lakhs versus Rs. 7,994.33 lakhs previously. Basic EPS improved significantly to Rs. 17.87 from Rs. 6.43. The Board recommended a final dividend of Rs. 4.50 per equity share (face value Rs. 2 each), subject to shareholder approval. Statutory auditors Walker Chandiok & Co LLP issued unmodified (clean) audit opinions on both standalone and consolidated results. The company operates in Ayurvedic products/medicines and healthcare services segments. M/s Forvis Mazars LLP was re-appointed as internal auditor for FY 2026-27.
The company delivered exceptional revenue and profit growth, demonstrating strong operational performance. The recommended dividend of Rs. 4.50 per share signals confidence in financial health and rewards shareholders. Clean audit opinions indicate reliable financial reporting.